Corporate Finance

With a new $2B share buyback and strong dividends, Royal Caribbean isn't just recovering; it's setting a new course for shareholder value and growth.

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?

Chatham Lodging Trust's dividend hike isn't just a payout. It’s a strategic signal about the future of upscale travel and savvy hotel investment.

With a massive lodge expansion and an all-inclusive dining plan, the cruise line is making a strategic play to dominate the lucrative Alaska land-tour market.

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.

An Indiana firm's move to an Employee Ownership Trust signals a major shift in corporate succession, with deep implications for stability and talent.

ADP's new retirement plan isn't just about lower fees. It's a tech-driven strategy to solve the SMB benefits gap and empower financial advisors.

A crypto fund's nomination for a top award signals a new era for family offices seeking managed risk and high returns in the volatile digital asset market.

Nomentia appoints a new CEO with a mandate for international growth, signaling a major shift in the competitive landscape of treasury management technology.

Beyond webinars, ON24's G2 win and LinkedIn pact reveal a strategic shift to AI-driven data and connected campaigns in the B2B marketing tech war.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

A routine filing reveals Marathon Asset Management's 3.68% stake in John Wood Group. What does this calculated play signal for the firm's takeover?

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

Del Webb's new Michigan community isn't just selling homes; it's selling a lifestyle. We dissect the business strategy behind its amenity-rich model.

Unisync Corp. engineered a dramatic return to profitability. We explore the deep operational changes and strategic wins that fueled this impressive turnaround.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

Aurora Mobile's EngageLab unveils a behavioral CAPTCHA to fight fraud without frustrating users, reshaping security for e-commerce and finance.